Key regions: United States, Europe, Brazil, Japan, United Kingdom
Bronchodilator drugs are a crucial part of the treatment for respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). In Bahrain, the market for bronchodilator drugs has been showing some interesting trends and developments.
Customer preferences: Bronchodilator drugs are primarily used to relieve symptoms such as coughing, wheezing, and shortness of breath in patients with respiratory diseases. In Bahrain, there is a growing preference for combination bronchodilator drugs that contain both short-acting and long-acting medications. This is because these drugs provide immediate relief as well as long-term control of symptoms.
Trends in the market: One of the major trends in the bronchodilator drugs market in Bahrain is the increasing demand for inhalers. Inhalers are preferred over other forms of medication such as tablets or syrups because they deliver the medication directly to the lungs, resulting in faster and more effective relief of symptoms. Another trend in the market is the growing popularity of generic bronchodilator drugs. These drugs are cheaper than their brand-name counterparts and are equally effective.
Local special circumstances: Bahrain has a high prevalence of respiratory diseases such as asthma and COPD. This is partly due to the country's hot and humid climate, which can trigger respiratory symptoms in susceptible individuals. Additionally, Bahrain has a high prevalence of smoking, which is a major risk factor for respiratory diseases. These local circumstances have contributed to the growth of the bronchodilator drugs market in Bahrain.
Underlying macroeconomic factors: Bahrain has a well-developed healthcare system that provides universal coverage to its citizens. This has led to increased access to healthcare services, including medications such as bronchodilator drugs. Additionally, Bahrain has a growing population, which has led to an increase in the number of individuals with respiratory diseases. These underlying macroeconomic factors have contributed to the growth of the bronchodilator drugs market in Bahrain.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
